Cargando…
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
SARS-CoV-2 vaccination has been launched worldwide to build effective population-level immunity to curb the spread of this virus. The effectiveness and duration of protective immunity is a critical factor for public health. Here, we report the kinetics of the SARS-CoV-2 specific immune response in 2...
Autores principales: | Feng, Chengqian, Shi, Jingrong, Fan, Qinghong, Wang, Yaping, Huang, Huang, Chen, Fengjuan, Tang, Guofang, Li, Youxia, Li, Pingchao, Li, Jiaojiao, Cui, Jianping, Guo, Liliangzi, Chen, Sisi, Jiang, Mengling, Feng, Liqiang, Chen, Ling, Lei, Chunliang, Ke, Changwen, Deng, Xilong, Hu, Fengyu, Tang, Xiaoping, Li, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370972/ https://www.ncbi.nlm.nih.gov/pubmed/34404803 http://dx.doi.org/10.1038/s41467-021-25312-0 |
Ejemplares similares
-
Interferon stimulated immune profile changes in a humanized mouse model of HBV infection
por: Wang, Yaping, et al.
Publicado: (2023) -
Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis
por: Huang, Huang, et al.
Publicado: (2020) -
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract
por: Hu, Fengyu, et al.
Publicado: (2020) -
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
por: Wang, Yaping, et al.
Publicado: (2021) -
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
por: Yu, Haisheng, et al.
Publicado: (2023)